부산대학교 도서관

Z. Mahmoudjafari; K. L. Rosettie; M. Wu; H. Figary; C. Reyes; E. Ma

Hematological Oncology. 43

Mahmoudjafari Z; The University of Kansas Health System, Kansas City, KS, USA.; Li J; Genentech, Inc, South San Francisco, CA, USA.; Bercaw E; Medicus Economics, LLC, Boston, MA, USA.; Parisé H; Medicus Economics, LLC, Boston, MA, USA.; Bognar K; Medicus Economics, LLC, Boston, MA, USA.; Wang ST; Medicus Economics, LLC, Boston, MA, USA.; Masaquel A; Genentech, Inc, South San Francisco, CA, USA.

Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

Bhutani M; Division of Hematology, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA. manisha.bhutani@advocatehealth.org.; Habib A; Division of Hematology, The Ohio State University, Columbus, OH, USA.; Vegel A; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.; Ndiaye A; Division of Hematology, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; Struble E; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.; Shaikh H; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.; Chang D; Division of Hematology, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; Strouse C; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.; Green KM; Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC, USA.; Graf K; Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC, USA.; Mushtaq MU; Division of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS, USA.; Mahmoudjafari Z; Division of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS, USA.; McGuirk JP; Division of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS, USA.; Voorhees P; Division of Hematology, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.; Khan AM; Division of Hematology, The Ohio State University, Columbus, OH, USA.; Abdallah AO; Division of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS, USA.; Ahmed N; Division of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Cancer Center, Kansas City, KS, USA.; Atrash S; Division of Hematology, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: In Process; MEDLINE

Mahmoudjafari Z; The University of Kansas Health System, Kansas City, KS, USA.; Di Maio D; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Li J; Genentech, Inc, South San Francisco, CA, USA.; Rosettie KL; Genentech, Inc, South San Francisco, CA, USA.; Masaquel A; Genentech, Inc, South San Francisco, CA, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Banez MT; Department of Pharmaceutical Services, University of California, San Francisco, California, USA.; Atienza S; Department of Pharmacy, Advocate Health Midwest, Milwaukee, Wisconsin, USA.; Butts A; Department of Pharmacy, UK HealthCare, Lexington, Kentucky, USA.; Derba M; Department of Pharmacy, Eastern Maine Medical Center, Bangor, Maine, USA.; Dicke K; Department of Pharmacy, OhioHealth, Columbus, Ohio, USA.; Haverstick K; Pharmacy and Therapeutics Service Line, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.; Heron BB; National Pharmacy Benefits Management, Hematology/Oncology, Department of Veterans Affairs, Hines, Illinois, USA.; Cimino SK; Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee, USA.; Loop MS; Department of Health Outcomes Research and Policy, Harrison College of Pharmacy, Auburn University, Auburn, Alabama, USA.; Hough S; The US Oncology Network, McKesson Specialty Health, The Woodlands, Texas, USA.; Merten JA; Chimeric Medical Communications, LLC, St Ansgar, Iowa, USA.; Moore DC; Department of Pharmacy, Atrium Health Levine Cancer Institute, Charlotte, North Carolina, USA.; Shah V; Department of Pharmacy, Mayo Clinic, Phoenix, Arizona, USA.; Taucher KD; Department of Pharmacy, UCHealth, Aurora, Colorado, USA.; Zhang JM; Department of Pharmacy, University of Chicago Medical Center, Chicago, Illinois, USA.; Mahmoudjafari Z; University of Kansas Health System, Kansas City, Kansas, USA.

Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

Mahmoudjafari, Z.; Rosettie, K. L.; Wu, M.; Figary, H.; Reyes, C.; Ma, E.

Hematological Oncology (HEMATOL ONCOL), 2025 Supplement; 43: 1-2. (2p)

Mansour R; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Green KM; Division of Hematology-Oncology, Medical University of South Carolina, Charleston, South Carolina, USA.; Graf C; Division of Hematology-Oncology, Medical University of South Carolina, Charleston, South Carolina, USA.; Chang M; Levine Cancer Institute/Wake Forest, Atrium Health, Charlotte, North Carolina, USA.; Magee G; Levine Cancer Institute/Wake Forest, Atrium Health, Charlotte, North Carolina, USA.; Davis JA; Division of Hematology-Oncology, Medical University of South Carolina, Charleston, South Carolina, USA.; Zayad A; Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.; Ahmed N; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mushtaq MU; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Ouchveridze E; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mahmoudjafari Z; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Paul B; Levine Cancer Institute/Wake Forest, Atrium Health, Charlotte, North Carolina, USA.; Twardowski N; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Atrash S; Levine Cancer Institute/Wake Forest, Atrium Health, Charlotte, North Carolina, USA.; Abdallah AO; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.

Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

Mahmoudjafari Z; The University of Kansas Cancer Center, Kansas City, Kansas. Electronic address: zmahmoudjafari@kumc.edu.; McGuirk J; The University of Kansas Cancer Center, Kansas City, Kansas.; Ahmed N; The University of Kansas Cancer Center, Kansas City, Kansas.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Ahmed N; Division of Hematological Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS, USA. Electronic address: Nahmed5@kumc.edu.; Mahmoudjafari Z; Division of Hematological Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS, USA.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: In Process; MEDLINE

Davis JA; Hollings Cancer Center, The Medical University of South Carolina, Charleston, SC, USA. davisjaa@musc.edu.; Snyder J; University of Kansas Cancer Center, Westwood, KS, USA.; Rice M; Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.; Moore DC; Levine Cancer Institute, Charlotte, NC, USA.; Cahoon C; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Julian K; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Wagner CB; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.; Granger K; Hollings Cancer Center, The Medical University of South Carolina, Charleston, SC, USA.; Green KM; Hollings Cancer Center, The Medical University of South Carolina, Charleston, SC, USA.; Atrash S; Levine Cancer Institute, Charlotte, NC, USA.; Hill H; Levine Cancer Institute, Charlotte, NC, USA.; McElwee J; Levine Cancer Institute, Charlotte, NC, USA.; Elsey G; Levine Cancer Institute, Charlotte, NC, USA.; Khouri J; Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.; Rudoni J; Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.; Mahmoudjafari Z; University of Kansas Cancer Center, Westwood, KS, USA.; Nachar VR; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: In Process; MEDLINE

Irfan S; Aga Khan University, Karachi, Pakistan. Electronic address: sohaibirfan910@gmail.com.; Ayoobkhan FS; Trinity Health Oakland/Wayne State University, Pontiac, Michigan.; Vojjala N; Trinity Health Oakland/Wayne State University, Pontiac, Michigan.; Qureshi R; University of Missouri-Kansas City, Kansas City, Missouri.; Rahman R; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas.; Kamboj I; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas; U.S. Myeloma Innovations Research Collaborative (USMIRC), Kansas City, Kansas State.; Abdallah AO; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas; U.S. Myeloma Innovations Research Collaborative (USMIRC), Kansas City, Kansas State.; McGuirk J; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas.; Mahmoudjafari Z; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas.; Lutfi F; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas.; Ahmed N; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Atallah, R.; Logan, E.; Mushtaq, M.U.; McGuirk, J.P.; Mahmoudjafari, Z.; Ahmed, N.; Abdallah, A.-O.; Shatnawi, Y.; Mammadzadeh, A.; Atrash, S.; Anwer, F.; Ayoobkhan, M.D.F.S.; Saif, M.S.I.; Naeem, M.; Rana, S.; Hashmi, S.K.; Mohamed, B.; Desai, N.; Carneiro, T.X.; Popat, R.; Hammad, N.

In: JCO Global Oncology. (JCO Global Oncology, 1 June 2025, 11)

Merz M; Department of Hematology, Cellular Therapy, Hemasteseology and Infectious Disease, University Hospital of Leipzig and Fraunhofer IZI, Leipzig, Germany. maximilian.merz@medizin.uni-leipzig.de.; Dima D; Cleveland Clinic, Cleveland, OH, USA.; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Hashmi H; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; The Medical University of South Carolina, Charleston, SC, USA.; Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Ahmed N; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS, USA.; Stölzel F; University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.; Holderried TAW; Department of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany.; Fenk R; Heinrich Heine University, University Hospital Düsseldorf, Düsseldorf, Germany.; Müller F; Department of Internal Medicine 5, Haematology and Oncology, University Hospital of Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany.; Tovar N; Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain.; Oliver-Cáldes A; Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain.; Rathje K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Davis JA; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; The Medical University of South Carolina, Charleston, SC, USA.; Fandrei D; Department of Hematology, Cellular Therapy, Hemasteseology and Infectious Disease, University Hospital of Leipzig and Fraunhofer IZI, Leipzig, Germany.; Vucinic V; Department of Hematology, Cellular Therapy, Hemasteseology and Infectious Disease, University Hospital of Leipzig and Fraunhofer IZI, Leipzig, Germany.; Kharboutli S; Department of Internal Medicine 5, Haematology and Oncology, University Hospital of Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany.; Baermann BN; Heinrich Heine University, University Hospital Düsseldorf, Düsseldorf, Germany.; Ayuk F; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Platzbecker U; Department of Hematology, Cellular Therapy, Hemasteseology and Infectious Disease, University Hospital of Leipzig and Fraunhofer IZI, Leipzig, Germany.; Albici AM; University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.; Schub N; University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.; Schmitz F; Department of Hematology, Oncology, Stem Cell Transplantation, Immune and Cell Therapy, Clinical Immunology and Rheumatology, University Hospital Bonn, Bonn, Germany.; Shune L; Cleveland Clinic, Cleveland, OH, USA.; Khouri J; Cleveland Clinic, Cleveland, OH, USA.; Anwer F; Cleveland Clinic, Cleveland, OH, USA.; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Raza S; Cleveland Clinic, Cleveland, OH, USA.; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; McGuirk J; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS, USA.; Mahmoudjafari Z; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS, USA.; Green K; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; The Medical University of South Carolina, Charleston, SC, USA.; Khandanpour C; Campus Lübeck, University Cancer Center Schleswig-Holstein and University of Lübeck, Lübeck, Germany.; Teichert M; Department of Medicine II, Division for Stem Cell Transplantation and Cellular Immunotherapy, Universitätsklinikum Essen, Essen, Germany.; Jeker B; Department of Medical Oncology, University Hospital Inselspital and University of Bern, Bern, Switzerland.; Hoffmann M; Department of Medical Oncology, University Hospital Inselspital and University of Bern, Bern, Switzerland.; Kröger N; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; von Tresckow B; Department of Medicine II, Division for Stem Cell Transplantation and Cellular Immunotherapy, Universitätsklinikum Essen, Essen, Germany.; de Larrea CF; Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain.; Pabst T; Department of Medical Oncology, University Hospital Inselspital and University of Bern, Bern, Switzerland.; Abdallah AO; US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, MO, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS, USA.; Gagelmann N; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Leidy S; From The University of Kansas Cancer Center, Westwood, Kansas.; Mahmoudjafari Z; From The University of Kansas Cancer Center, Westwood, Kansas.

Publisher: BroadcastMed LLC Country of Publication: United States NLM ID: 101550346 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2150-0878 (Print) Linking ISSN: 21500878 NLM ISO Abbreviation: J Adv Pract Oncol

Snyder J; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Atrash S; Levine Cancer Center, Atrium Health, Wake Forest University School of Medicine, Charlotte, NC 27103, USA.; Paul B; Levine Cancer Center, Atrium Health, Wake Forest University School of Medicine, Charlotte, NC 27103, USA.; Khan AM; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.; Habib A; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.; Shaikh H; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA 52242, USA.; Strouse C; Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA 52242, USA.; Alkharabsheh O; Division of Hematology and Oncology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.; Mazloom A; Division of Hematology and Oncology, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.; Ahmed N; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Mahmoudjafari Z; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Mushtaq MU; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Zayad A; Department of Internal of Medicine, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.; McGuirk J; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Tiger YK; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ 08903, USA.; Shah MR; Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ 08903, USA.; Abdallah AO; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Kamboj I; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS; Collaborative Opportunities for Research, Training, and Excellence in Innovation (CORTEX), Westwood, KC. Electronic address: i.ishitakamboj@gmail.com.; Habib A; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Chang D; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC.; Rashid A; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS.; Vegel A; Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA.; Graf K; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS; Division of Hematology Oncology, Medical University of South Carolina, Charleston, SC.; Struble E; Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA.; Mushtaq MU; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS.; Mahmoudjafari Z; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS.; Green K; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS; Division of Hematology Oncology, Medical University of South Carolina, Charleston, SC.; Khan AM; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.; Strouse CS; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS; Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA.; McGuirk JP; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS.; Hashmi H; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS; Division of Hematology Oncology, Medical University of South Carolina, Charleston, SC; Division of Hematology-oncology, Memorial Sloan Kettering Cancer Center, New York City, NY.; Shaikh H; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS; Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA.; Atrash S; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute/Atrium Health, Charlotte, NC.; Abdallah AO; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS.; Ahmed N; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS; US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS; Collaborative Opportunities for Research, Training, and Excellence in Innovation (CORTEX), Westwood, KC.

Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Weise M; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Atrash S; Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine, Charlotte, NC 28204, USA.; Ansari B; Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205, USA.; Mushtaq MU; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; McGuirk J; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Abdallah AO; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Mahmoudjafari Z; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.; Ahmed N; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS 66205, USA.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE

Khouderchah CJ; Department of Pharmacy Services and Clinical Pharmacy, Michigan Medicine, Ann Arbor, MI, USA.; Ochs M; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.; Pianko M; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.; Mahmoudjafari Z; Department of Pharmacy, University of Kansas Cancer Center, Kansas City, KS, USA.; Snyder J; Department of Pharmacy, University of Kansas Cancer Center, Kansas City, KS, USA.; Ahmed I; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.; Campagnaro E; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.; Nachar VR; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA.

Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

Mahmoudjafari Z; Division of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Cancer Center, Westwood, KS.; Kintsch E; Incyte Corporation, Wilmington, DE.; Xue Z; Incyte Corporation, Wilmington, DE.; Bhatt V; Incyte Corporation, Wilmington, DE.; Galvin J; Incyte Corporation, Wilmington, DE.; Locatelli F; Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.; Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, Rome, Italy.; Zeiser R; Department of Medicine, University Medical Center Freiburg, Freiburg, Germany.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Shahzad M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; H. Lee Moffitt Cancer Center, Tampa, Florida, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Amin MK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Bellman P; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Al-Ramahi J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Noor J; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Vyas A; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mahmoudjafari Z; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; McGuirk M; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; DeJarnette S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Ahmed N; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Abdallah AO; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Shune L; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Singh AK; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; McGuirk JP; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Abhyankar S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.; Mushtaq MU; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA.; Mikael Rayaan Foundation Global Health Consortium, Kansas City, USA.

Publisher: American Association Of Blood Banks Country of Publication: United States NLM ID: 0417360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-2995 (Electronic) Linking ISSN: 00411132 NLM ISO Abbreviation: Transfusion Subsets: MEDLINE